Status:
UNKNOWN
Precision Immunology to Determine the Immune Response in Patients With COVID-19
Lead Sponsor:
University of Bonn
Conditions:
SARS-CoV 2
COVID
Eligibility:
All Genders
18+ years
Brief Summary
To better understand the immune response to SARS-CoV-2 infection, we devised a precision immunology approach to systematically study the immune function of different patient cohorts
Eligibility Criteria
Inclusion
- SARS-Cov2 positive PCR
Exclusion
- pregnancy
Key Trial Info
Start Date :
April 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04360733
Start Date
April 20 2020
End Date
September 1 2022
Last Update
May 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Bonn
Bonn, Germany, 53127